Zhejiang Sunflower Great Health Co., Ltd. (SHE:300111)

Market Cap	5.07B +21.6%
Revenue (ttm)	302.92M -8.3%
Net Income	6.35M +956.5%
EPS	0.01 +1,077.0%
Shares Out	1.29B
PE Ratio	798.90
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	56,795,739
Average Volume	44,327,044
Open	3.890
Previous Close	4.130
Day's Range	3.890 - 4.120
52-Week Range	2.330 - 10.280
Beta	0.62
RSI	46.48
Earnings Date	Apr 22, 2026

About SHE:300111

Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs in China and internationally. It offers clarithromycin API and tablets, anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, Mycoplasma pneumonia, and urethritis and cervicitis; and azithromycin dispersible tablets and injections for sinusitis, acute otitis media, acute bronchitis, acute e...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 331
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300111

Financial Performance

In 2024, SHE:300111's revenue was 330.37 million, a decrease of -2.38% compared to the previous year's 338.42 million. Earnings were 7.83 million, a decrease of -64.01%.